Edward W Scott
Overview
Explore the profile of Edward W Scott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
2662
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ligocki A, Vinson A, Yachnis A, Dunn Jr W, Smith D, Scott E, et al.
Sci Adv
. 2024 Sep;
10(36):eadn3259.
PMID: 39231237
Cerebrospinal fluid (CSF) is responsible for maintaining brain homeostasis through nutrient delivery and waste removal for the central nervous system (CNS). Here, we demonstrate extensive CSF flow throughout the peripheral...
2.
Ligocki A, Vinson A, Yachnis A, Dunn W, Smith D, Scott E, et al.
bioRxiv
. 2023 Dec;
PMID: 38045235
One Sentence Summary: Cerebrospinal fluid unites the nervous system by extending beyond the central nervous system into peripheral nerves.
3.
Shenoy A, Pi L, Ligocki A, Hosaka K, Cogle C, Scott E
Stem Cell Rev Rep
. 2023 Jan;
19(4):928-941.
PMID: 36652143
Neovascularization is a key therapeutic target for cancer treatment. However, anti-angiogenic therapies have shown modest success, as tumors develop rapid resistance to treatment owing to activation of redundant pathways that...
4.
Pessa J, Smith D, Sieber D, Kenkel J, Arbique G, Nahai F, et al.
Aesthet Surg J
. 2020 Aug;
41(10):1197-1206.
PMID: 32827254
Background: During their work on the cerebrospinal fluid (CSF) circulatory system of human nerves and brain, the authors applied imaging and tissue techniques that complemented basic anatomical dissection. Objectives: The...
5.
Fu C, Lu Y, Williams M, Brantly M, Ventetuolo C, Morel L, et al.
Br J Pharmacol
. 2019 Dec;
178(1):187-202.
PMID: 31793661
Background And Purpose: Pulmonary hypertension (PH) secondary to chronic lung disease (World Health Organization Group 3 PH) is deadly, with lung transplant being the only available long-term treatment option. Myeloid-derived...
6.
Oliveira A, Fu C, Lu Y, Williams M, Pi L, Brantly M, et al.
Am J Physiol Lung Cell Mol Physiol
. 2019 Aug;
317(4):L434-L444.
PMID: 31364370
Pulmonary hypertension complicates the care of many patients with chronic lung diseases (defined as Group 3 pulmonary hypertension), yet the mechanisms that mediate the development of pulmonary vascular disease are...
7.
Fisher R, Bellamkonda K, Alex Molina L, Xiang S, Liska D, Sarvestani S, et al.
Neoplasia
. 2019 Feb;
21(3):269-281.
PMID: 30738331
Dysfunctional inflammatory pathways are associated with an increased risk of cancer, including colorectal cancer. We have previously identified and enriched for a self-renewing, colon cancer stem cell (CCSC) subpopulation in...
8.
Pi L, Fu C, Lu Y, Zhou J, Jorgensen M, Shenoy V, et al.
Front Physiol
. 2018 Mar;
9:138.
PMID: 29535639
Chronic hypoxia frequently complicates the care of patients with interstitial lung disease, contributing to the development of pulmonary hypertension (PH), and premature death. Connective tissue growth factor (CTGF), a matricellular...
9.
Bryant A, Shenoy V, Fu C, Marek G, Lorentsen K, Herzog E, et al.
Am J Respir Cell Mol Biol
. 2017 Sep;
58(2):170-180.
PMID: 28862882
Pulmonary hypertension (PH) complicates the care of patients with chronic lung disease, such as idiopathic pulmonary fibrosis (IPF), resulting in a significant increase in morbidity and mortality. Disease pathogenesis is...
10.